Skip to main content
Erschienen in: Journal of Cancer Education 2/2016

08.05.2015

Impact of Physiological Symptoms and Complications of Colorectal Cancer on the Quality of Life of Patients at King Abdulaziz University Hospital

verfasst von: Faisal F. Alabbas, Ssakher M. Al-Otaibi, Majed H. Chamsi Pasha, Abdullah M. Alghamdi, Hisham M. Al-Hindi, Mahmoud S. Al-Ahwal, Basem S. El-Deek

Erschienen in: Journal of Cancer Education | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Colorectal cancer (CRC) is common worldwide. The high prevalence of the disease raises concerns about how CRC influences the health-related quality of life (QoL). To explore the impact of physiological symptoms and complications of CRC on patients’ QoL, we conducted a cross-sectional survey using the FACT-C self-report instrument. The chi-square test was used to compare qualitative data. We found that pain was reported by most of the patients (n = 31; 77.5 %). Furthermore, male patients were more likely to complain of pain “mostly” as compared with females (P = .032). We found no significant differences between genders regarding general health-related questions. A greater proportion of male patients often complained of abdominal cramps (P = .542), weight loss (P = .086), and diarrhea (P = .408). More than half of the patients (n = 26; 65 %) reported having a good appetite; a greater proportion of males reported having a good appetite “mostly” (P = .014). Social and psychological qualities of life were not significantly different between male and female patients. Male and female patients did not differ in their report of disease acceptance (P = .420) and ability to enjoy life (P = .744). No difference was also found between genders regarding contentment with QoL (P = .793) or ability to sleep well (P = .695). Furthermore, there were no differences between genders regarding job fulfillment (P = .272). Our results add to the growing body of knowledge about the effect of CRC on QoL. Importantly, the differences in self-reported pain and appetite between male and female patients in our study suggest the importance of gender-based treatments in improving patients’ QoL.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F et al. (2010) GLOBOCAN 2008 v2.0. Cancer incidence and mortality worldwide: IARC CancerBase No.10. Internal Agency for Research on Cancer website. http://globocan.iarc.fr. Accessed 15 March 2015 Ferlay J, Shin HR, Bray F et al. (2010) GLOBOCAN 2008 v2.0. Cancer incidence and mortality worldwide: IARC CancerBase No.10. Internal Agency for Research on Cancer website. http://​globocan.​iarc.​fr. Accessed 15 March 2015
2.
Zurück zum Zitat Mosli MH, Al-Ahwal MS (2012) Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev 13(8):3809–3813CrossRefPubMed Mosli MH, Al-Ahwal MS (2012) Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev 13(8):3809–3813CrossRefPubMed
3.
Zurück zum Zitat Siraj AK, Khalak HG, Sultana M et al. (2012) Colorectal cancer risk is not associated with increased levels of homozygosity in Saudi Arabia. Genet Med Siraj AK, Khalak HG, Sultana M et al. (2012) Colorectal cancer risk is not associated with increased levels of homozygosity in Saudi Arabia. Genet Med
4.
Zurück zum Zitat Sibiani A, Shaheen M, Fallatah HI et al (2011) Colorectal cancer in Saudi Arabia King Abdul Aziz University Hospital: a five year experience. J Med Medic Sci 2:1126–1130 Sibiani A, Shaheen M, Fallatah HI et al (2011) Colorectal cancer in Saudi Arabia King Abdul Aziz University Hospital: a five year experience. J Med Medic Sci 2:1126–1130
6.
Zurück zum Zitat Al-Ahwal MS, Shafik YH, Al-Ahwal HM (2013) First national survival data for colorectal cancer among Saudis between 1994 and 2004: what’s next? BMC Public Health 25;13:73 Al-Ahwal MS, Shafik YH, Al-Ahwal HM (2013) First national survival data for colorectal cancer among Saudis between 1994 and 2004: what’s next? BMC Public Health 25;13:73
8.
Zurück zum Zitat Baade PD, Youlden DR, Chambers SK (2011) When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 194:73PubMed Baade PD, Youlden DR, Chambers SK (2011) When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 194:73PubMed
9.
Zurück zum Zitat Deimling GT, Sterns S, Bowman KF, Kahana B (2007) Functioning and activity participation restrictions among older adult. Long-Term Canc Surv Canc Investig 25(2):106–116 Deimling GT, Sterns S, Bowman KF, Kahana B (2007) Functioning and activity participation restrictions among older adult. Long-Term Canc Surv Canc Investig 25(2):106–116
10.
Zurück zum Zitat Rees JR, Blazeby JM, Brookes ST, John T, Welsh FK, Rees M (2014) Patient-reported outcomes in long-term survivors of metastatic colorectal cancer needing liver resection. Br J Surg 101(11):1468–1474CrossRefPubMed Rees JR, Blazeby JM, Brookes ST, John T, Welsh FK, Rees M (2014) Patient-reported outcomes in long-term survivors of metastatic colorectal cancer needing liver resection. Br J Surg 101(11):1468–1474CrossRefPubMed
12.
Zurück zum Zitat Ramage-Morin PL, Gilmour H (2010) Chronic pain at ages 12 to 44. Health Rep 21(4):53–61PubMed Ramage-Morin PL, Gilmour H (2010) Chronic pain at ages 12 to 44. Health Rep 21(4):53–61PubMed
13.
Zurück zum Zitat Hussain AM, Khan FA, Ahmed A et al (2013) Effect of gender on pain perception and analgesic consumption in laparoscopic cholecystectomy: an observational study. J Anaesthesiol Clin Pharmacol 29(3):337–341CrossRefPubMedPubMedCentral Hussain AM, Khan FA, Ahmed A et al (2013) Effect of gender on pain perception and analgesic consumption in laparoscopic cholecystectomy: an observational study. J Anaesthesiol Clin Pharmacol 29(3):337–341CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kvachadze I, Tsagareli M, Dumbadze Z (2015) An overview of ethnic and gender differences in pain sensation. Georgian Med News 238:102–108PubMed Kvachadze I, Tsagareli M, Dumbadze Z (2015) An overview of ethnic and gender differences in pain sensation. Georgian Med News 238:102–108PubMed
16.
Zurück zum Zitat Denlinger CS, Barsevick AM (2009) The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 7(8):883–893, quiz 894 PubMedPubMedCentral Denlinger CS, Barsevick AM (2009) The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 7(8):883–893, quiz 894 PubMedPubMedCentral
17.
Zurück zum Zitat Nicolussi AC, Sawada NO (2009) Quality of life of patients with colorectal cancer who were receiving complementary therapy. Acta Paul Enferm 22(2):155–161CrossRef Nicolussi AC, Sawada NO (2009) Quality of life of patients with colorectal cancer who were receiving complementary therapy. Acta Paul Enferm 22(2):155–161CrossRef
18.
Zurück zum Zitat Santos EMM, Rossi BM, Lourenço MTC (2011) Predictors of quality of life in colorectal cancer patients treated with curative intention. Appl Cancer Res 31(3):87–91 Santos EMM, Rossi BM, Lourenço MTC (2011) Predictors of quality of life in colorectal cancer patients treated with curative intention. Appl Cancer Res 31(3):87–91
19.
Zurück zum Zitat Mosconi P, Apolone G, Barni S et al (2002) Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires. Tumori 88:110–116PubMed Mosconi P, Apolone G, Barni S et al (2002) Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires. Tumori 88:110–116PubMed
20.
21.
Zurück zum Zitat Thoresen L, Frykholm G, Lydersen S et al (2012) The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl) 21(4):505–516CrossRef Thoresen L, Frykholm G, Lydersen S et al (2012) The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl) 21(4):505–516CrossRef
22.
Zurück zum Zitat Schmidt CE, Bestmann B, Küchler T et al (2005) Ten-year historic cohort of quality of life and sexuality in patients with rectal cancer. Dis Colon Rectum 48(3):483–492CrossRefPubMed Schmidt CE, Bestmann B, Küchler T et al (2005) Ten-year historic cohort of quality of life and sexuality in patients with rectal cancer. Dis Colon Rectum 48(3):483–492CrossRefPubMed
23.
Zurück zum Zitat Moon H, Ju Y, Jeong C et al (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15(7):1918–1922CrossRefPubMed Moon H, Ju Y, Jeong C et al (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15(7):1918–1922CrossRefPubMed
24.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 1 112(11 Suppl):2577–2592 Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 1 112(11 Suppl):2577–2592
25.
Zurück zum Zitat Paika V, Almyroudi A, Tomenson B et al (2010) Personality variables are associated with colorectal cancer patients’ quality of life independent of psychological distress and disease severity. Psycho-Oncology 19(3):273–282CrossRefPubMed Paika V, Almyroudi A, Tomenson B et al (2010) Personality variables are associated with colorectal cancer patients’ quality of life independent of psychological distress and disease severity. Psycho-Oncology 19(3):273–282CrossRefPubMed
26.
Zurück zum Zitat Dunn J, Ng SK, Breitbart W (2013) Health-related quality of life and life satisfaction in colorectal cancer survivors: trajectories of adjustment. Health Qual Life Outcomes 14 11:46CrossRef Dunn J, Ng SK, Breitbart W (2013) Health-related quality of life and life satisfaction in colorectal cancer survivors: trajectories of adjustment. Health Qual Life Outcomes 14 11:46CrossRef
Metadaten
Titel
Impact of Physiological Symptoms and Complications of Colorectal Cancer on the Quality of Life of Patients at King Abdulaziz University Hospital
verfasst von
Faisal F. Alabbas
Ssakher M. Al-Otaibi
Majed H. Chamsi Pasha
Abdullah M. Alghamdi
Hisham M. Al-Hindi
Mahmoud S. Al-Ahwal
Basem S. El-Deek
Publikationsdatum
08.05.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2016
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0839-7

Weitere Artikel der Ausgabe 2/2016

Journal of Cancer Education 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.